Print this page
Back to Web version of article
The Body Covers: The 12th International AIDS Conference
Poster Session 60484: Indinavir 12 hour Dosing an Alternative to 8 Hourly Dosing Regimen: A Pilot Study
July 3, 1998
This was another in a series of trials looking at the effectiveness of easier dosing regimens of indinavir. Dr. Young and her colleagues looked at two groups of patients, one taking indinavir at the current dose of 800 mg every 8 hours, in combination with 2 nucleoside reverse transcriptase inhibitors, and the other taking their nukes in combination with indinavir dosed at 1200 mg every 12 hours. This study was small, a total of 25 patients, but confirmed the findings of other studies of twice-daily indinavir -- namely, there was no statistical difference between the groups in either viral load decrease or CD4 cell count rise. There was no difference in side effects. While we do need larger, more controlled trials, this study suggests that twice-daily indinavir, in combination with two RTIs, may be as effective as the current dose schedule, and may help improve adherence.
This article was provided by TheBodyPRO.com. Copyright © Body Health Resources Corporation. All rights reserved.
You can find this article online by typing the following address into your Web browser:
Please Note: Knowledge about HIV changes rapidly. Note the date of this article's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this article.
General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your healthcare provider.